The Influence of Various Body Fluids and pH on E. Coli MIC of Quinolone Derivatives

  • T. C. Gasser
  • E. H. Larsen
  • T. Dørflinger
  • P. O. Madsen
Part of the Fortschritte der Urologie und Nephrologie book series (2824, volume 27)


Great efforts have been made to treat chronic bacterial prostatitis but the results have been disappointing, possibly due to poor drug penetration in the prostate (9, 10).


Minimum Inhibitory Concentration Human Urine Prostatic Tissue Antimicrob Agent Inoculum Size 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Barry AS, Jones RN, Thornsberry C, Ayers LW, Gerlach EH, Sommers HM (1984) Antibacterial activities of ciprofloxacin, norfloxacin oxolinic acid, cinoxacin, and nalidixic acid. Antimicrob Agents Chemother 25: 633PubMedGoogle Scholar
  2. 2.
    Chin NX, Neu HC (1983) In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new ß-lactams, aminoglycosides, and trimethoprim. Antimicrob Agents Chemother 24: 754PubMedGoogle Scholar
  3. 3.
    Fair WR, Cordonnier JJ (1978) The pH of prostatic fluid: a reappraisal and therapeutic implications. J Urol 120: 695PubMedGoogle Scholar
  4. 4.
    Iravani A, Welty GS, Newton BR, Richard GA (1985) Effects of changes in pH, medium, and inoculum size on the in vitro activity of amifloxacin against urinary isolates of Staphylococcus saprophytics and Escherichia coli. Antimicrob Agents Chemother 27: 449PubMedGoogle Scholar
  5. 5.
    Jacobus NV, Tally FP, Barza M (1984) Anti-microbial sprectrum of Win 49375. Antimicrob Agents Chemother 26: 104PubMedGoogle Scholar
  6. 6.
    Lennette EH, Balows A, Hausler WJ Jr, Truant JP (1980) Manual of Clinical Microbiology. 3rd ed. Am Soc Microbiology, Washington, D.C., p 453Google Scholar
  7. 7.
    Madsen PO, Whalen PR (1978) Interaction between antimicrobial agents and prostatic tissue extract and fluid. Infection (suppl 1) 6: 75Google Scholar
  8. 8.
    Mett H, Gyr K, Zak O, Vosbeck K (1984) Duodeno-pancreatic secretions enhance bactericidal activity of antimicrobial drugs. Antimicrob Agents Chemother 26: 35PubMedGoogle Scholar
  9. 9.
    Pfau A, Sacks T (1976) Chronic bacterial prostatitis: new therapeutic aspects. Br J Urol 48: 245PubMedGoogle Scholar
  10. 10.
    Stamey TA, Meares EH Jr, Winningham DG (1970) Chronic bacterial prostatitis and the diffusion of drugs into prostatic fluid. J Urol 103: 187PubMedGoogle Scholar
  11. 11.
    Stille W (1983) The prognostic value of the antibiogram. Infection (suppl 2) 11: 66CrossRefGoogle Scholar
  12. 12.
    Thompson DK, O’Keefe JP, Tatarowicz WA (1984) In vitro comparison of amifloxacin and six other antibiotics against aminoglycoside- resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 26: 275PubMedGoogle Scholar

Copyright information

© Dr. Dietrich SteinkopffVerlag & Co. KG, Darmstadt 1992

Authors and Affiliations

  • T. C. Gasser
    • 1
  • E. H. Larsen
    • 1
  • T. Dørflinger
    • 1
  • P. O. Madsen
    • 1
  1. 1.Urology Section, William S. Middleton Memorial Veterans Hospital and Department of SurgeryUniversity of Wisconsin School of MedicineMadisonUSA

Personalised recommendations